GenSci139

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GenSci139, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: GenSci139 in Patients With Advanced Solid Tumors [Phase 1]